CLINICAL_TRIALS
research
· 2024-10-21
Clinical Trial Update: A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia [Phase 3]
Summary
An update on a Phase 3 trial evaluating olanzapine-samidorphan tablets for schizophrenia, with the study currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: NOT_YET_RECRUITING